Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Panacos is developing the next generation of anti-infective products through discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. HIV infects approximately 1.7 million people in North America and Western Europe and approximately 40 million people worldwide. Approximately 650,000 patients are treated annually for HIV in the United States and Western Europe. Resistance to currently available drugs is one of the most pressing problems in HIV therapy and the leading cause of treatment failure. Panacos’ proprietary discovery technologies are designed to combat resistance by focusing on novel targets in the virus life cycle, including virus maturation and virus ( www.panacos.com )
Panacos Pharmaceuticals , Inc.
134 Coolidge Avenue
Watertown, Massachusetts 02472
USA
Tel: (617) 926-1551
Fax: (617) 923-2245